This is a limited company view. Sign up for a Free Trial to see everything.

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Copenhagen

Founded

1999

Employees

313

Stage

Late

Total funding

$157M

Last funding

8 years ago

Acquisitions

0

Growth score

363

Mindshare score

255

Scoring

Deals

$134.0M Venture

Jul 1, 2010

$23.0M Venture

GlaxoSmithKline

Oct 1, 2009

Other Investors

Index Ventures

Employee Growth

Use Genmab's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Genmab's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Associate Project Manager, Pharmaceutical Development
Director, IPR
Rådgiver indenfor general erhvervsret og kontraktforhandling, Senior Director, Head of Legal
Associate Director Business Development
Associate Director Finance & Accounting
Associate Director Cell and Molecular Science
Director, IT
Associate Director Assay and BioAnalytical Science
Associate Director Project Management Office
Director Alliance Management
Director Nonclinical Safety
Principal Scientist, Lead Generation
Associate Director Cell Molecular Science Operations & Quality Management
Associate Director, Process Development
Associate Director CMC
Associate Director, Finance & Accounting
Director of Quality
Director, Regulatory Affairs

Similar Companies

arGEN-X

Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineering antibodies to target diseases too complex for other antibody technologies.
Public|77 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes